First-line osimertinib for leptomeningeal metastasis from lung adenocarcinoma with EGFR mutation as the initial and solitary site of postoperative recurrence

Leptomeningeal metastasis (LM) from lung cancer has poor prognosis, and effective therapy has not been established. We present the case of a 54-year-old man with LM from lung adenocarcinoma harboring EGFR L858R point mutation, who received osimertinib as first-line therapy. He had previously undergo...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int Cancer Conf J
Main Authors: Ono, Yuki, Takada, Kazuki, Osoegawa, Atsushi, Kinoshita, Fumihiko, Oba, Taro, Tsukamoto, Shuichi, Tagawa, Tetsuzo, Oda, Yoshinao, Mori, Masaki
פורמט: Artigo
שפה:Inglês
יצא לאור: Springer Singapore 2020
נושאים:
Case Report
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7797384/
https://ncbi.nlm.nih.gov/pubmed/33489707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-020-00453-z
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים